Accendra Health Inc <ACH.N>: Baird cuts to neutral rating; cuts target price to $1.5 from $6
ACH•Related News
CTT Pharmaceutical CEO Ryan Khouri acquires 3,500 shares for $175
CTTH•
Block director Eisen Anthony Mathew disposes of USD 1.44 million in common shares
SQ•
Marriott International Signs Agreement With CP Group For Three Hotels In New Zealand
MAR•
New Fortress Energy appoints Frederick Hundt as interim CFO on September 3, 2026 - SEC filing
NFE•
Revolution Medicines director Lorence H. Kim disposes of 17,090 common shares worth USD 3.57 million
RVMD•